The BacTerminator technique is unique, and Adept Water Technologies intends to be a leading company in the field of infection control in Health Care and water disinfection. To achieve this goal, Adept Water Technologies seeks reliable partners and investors.
Please contact our CEO Michael Wick for more information. Contact
With the BacTerminator®, Adept has developed a new method for infection control for Health Care and water solutions without addition of chemicals.
The BacTerminator ® technology is based on a patented electrolysis process.
The technological development and market validation were financed by the current owners of the company.
In the opinion of management, the time is right to expand marketing and sales, and thus to secure a significant share of the market in wound care and water disinfection.
Electro-chemically activated water (ECA water)/hypochlorous acid is a technology which researchers consider to have significant potential for health care related purposes. ECA is of interest because it has broad-spectrum antimicrobial properties and also combats biofilm. At the same time, it has been demonstrated in many studies that ECA water is safe and has minimum toxicity, and it is biocompatible even in concentrations much higher than those which would be used in human treatments.
The table shows all the applications which have been tested and published as pre-clinical and clinical studies.
Tested on many wound types: chronic sores (diabetic foot sores, pressure sores, burns, venous leg ulcers, postoperative sores etc.)
|Other applications||Dental||Disinfection of medical equipment|
|Cleansing/rinsing solutions (high pressure and low pressure)||Treatment of acne-related skin problems||Cleansing solution for root canal treatment||Dental unit water system|
|Wound dressing||Disinfection of the eye surface||Tooth irrigation||Endoscope|
|Cleansing solution for negative pressure wound therapy||Treatment of rhinovirus infection||Periodontitis
|Peritoneal washing (washing out of infection etc.) during abdominal surgery (abscess, ruptured appendix)||Treatment of infection in connection with implant
|Antiseptic scrub (preventive)|
There are several commercial wound-care products that contain ECA water/stabilised hypochlorous acid. These are often sold in bottles and are therefore not produced on-site. It is claimed that some of the commercial products may be used for other forms of treatment but it has not been possible to find documented evidence of this.
It is evident that more products of this type are emerging and there are many scientific articles about the use of the technology for treatment/disinfection in hospitals. It is also evident that the earlier publications focused mainly on in vitro/in vivo studies, while in recent years there have been many published reports of clinical studies.
These have been based on small groups of patients but they have all shown a positive effect. 2016 saw publication of a large study on wound care with convincing results and it is likely that there will be more major studies in the near future. A common feature of all the clinical studies is that observed side effects are either non-existent or only occasional and very mild.
The first articles on the subject date back to the First World War, when hypochlorous acid was used for wound care. Since 2000, approx. 10 articles on the subject have been published annually.
There are many types of wound care but rinsing, cleansing, disinfection and application of products which promote wound healing are commonn to almost all treatments.
The most commonly used product is tap water. It is cheap, but the microbial quality is often questionable. In addition, the following are used:
Within the health care sector, one of the challenges associated with wound rinsing solutions is their high price, which leads to economies in their use. Often, tap water of questionable quality is used instead of isotonic saline or sterile water due to the price. Ultimately, this means increased expenses for hospital beds (longer admissions).
If instead of buying these ready-made solutions (wound rinsing solutions, sterile water, isotonic saline), hospitals were able to produce them directly from tap water they would achieve great cost reductions. If, in addition, the solution could be produced at a price which would make it an alternative to tap water the market would be huge.
With a global market within which more than 5 million bedridden patients require daily wound care and with wound care also taking place on an outpatient basis, at the general practitioner, in nursing homes and in private homes, the total market for wound care solutions is huge.
Theoretically a large part of this market for different types of rinsing and wound cleansing solutions could be replaced by a system like our BacTerminator Dental.
So there is a great economic incentive to change from one type of product to another. If part of the cost reduction is used to increase/improve wound care (more extensive use of wound rinsing solutions), there will also be a reduction in the number of beds occupied, which will generate additional cost reductions.